Harvard Infectious Diseases In Adults 2025

• Target Audience: infectious diseases physicians, internists, hospitalists, family physicians, pulmonologists, critical care physicians, emergency medicine physicians
• Sample video: contact me for sample video
• Information:

State-of-the-Art Approaches to Prevention, Diagnosis, and Treatment of Infectious Diseases

Infectious Diseases in Adults 2025 will be held online this year, using live streaming technology and live question and answer sessions.

OVERVIEW

This comprehensive CME program ensures attendees are current with state-of-the-art approaches to prevention, diagnosis, and treatment of infectious diseases. Updates, best practices, and new guidelines are presented by nationally recognized ID experts and master clinicians. Education is practical and results-driven:

Optimal decision-making in the prevention, diagnosis, and treatment of infectious diseases

Newer antimicrobials and treatment strategies for highly resistant infections

Prevention and treatment of infections in immunocompromised hosts

Update on antifungal diagnostics and therapy

State-of-the-art and multidisciplinary approaches to common infections

Clinical approaches to complex, rare, and “don’t-miss” infections

New, evolving, emerging, and re-emerging infectious diseases

Infections in persons with substance use disorder

What’s new in HIV prevention and management

The latest on COVID-19, including long COVID

Highlights of the 2025 Program

Expanded Case-Based and Problem-Solving Education

Treating Highly Resistant Infections, including:

MRSA and VISA (vancomycin-intermediate Staph aureus)

Extended-spectrum beta-lactamase (ESBL)-producing Gram-negative rods

Carbapenemase-producing Gram-negative rods, including NDM-1 metallo-beta-lactamase-producing organisms

Vancomycin-resistant enterococci (VRE)

Aspergillus and non-aspergillus mold infections

Candida auris

Nontuberculous mycobacteria (NTM)

Common Infectious Diseases: Updates in Prevention, Diagnosis, and Treatment

Updates to keep you current on new strategies, state-of-the-art practices, and the most recent guidelines to address:

Respiratory viral infections, including COVID-19

New and updated vaccines

Infections in the expanding populations of immunocompromised hosts

Infections in persons with substance use disorder

Infections of travelers and foreign-born persons

Systemic fungal infections

Native and device-related orthopedic infections

Central nervous system (CNS) infections

Ear, nose, and throat (ENT) and eye infections

Skin and soft tissue infections

Bronchiectasis and pneumonia

HIV and its infectious and noninfectious complications

PEP (Post-Exposure Prophylaxis) and PrEP (Pre-Exposure Prophylaxis) to prevent HIV infection

Sexually transmitted infections (STIs), including mpox and PEP for prevention of STIs

Hepatitis B and C infections

Tick- and mosquito-borne infections

Clostridioides difficile infection

Complicated urinary tract infections

Intra-abdominal infections

Challenging, Rare, and Emerging Infectious Diseases

Comprehensive updates on:

Rare and emerging infectious diseases, including highly pathogenic avian flu and Marburg virus

Re-emergence of vaccine-preventable diseases, including poliomyelitis

Pulmonary and extrapulmonary non-tuberculous (“atypical”) mycobacteria, including Mycobacterium abscessus

Global infectious diseases of clinical importance

Clinical Decision-Making

Hear directly from world-renowned specialists and master clinicians on their approach and decision-making criteria for:

Selecting the best antimicrobial and duration of treatment

Rapid detection and empiric treatment of life-threatening infectious diseases

Choosing between inpatient and outpatient treatment, and between intravenous and oral antimicrobials

Optimizing empiric antimicrobial therapy: what to start, and when to narrow or stop

Our multidisciplinary talks and workshops incorporate safety, quality, and practice improvement in infectious diseases, including:

Antimicrobial stewardship to prevent resistance and reduce cost

Infection control to reduce transmission in health care settings

Early inpatient ID consultations to improve outcomes

Strategies for management of infection in persons who inject drugs (PWID)

Optimized for Remote Education

The 2025 program has been enhanced for distance learning. In addition to being live streamed, all session recordings will be made available to participants for online viewing for 90 days after the end of the course.

New in 2025

The 2025 program adds coverage of:

Vaccine updates

The latest on respiratory viral infections

Infectious disease outbreaks of concern: highly pathogenic avian flu and Marburg virus

ID and critical care

Who Should Attend

Physicians, Nurse Practitioners, Physician Assistants, and Pharmacists in the fields of:

Infectious Diseases

Hospital Medicine

Internal Medicine

Family Practice

Pulmonary and Critical Care Medicine

Emergency Medicine

…and others who care for patients with infectious diseases

• Topics:

1. Schedule.pdf

2. Uyeki Plenary will not be recorded (please read).pdf

3. CPC Embargo (please read).pdf

Day 1 An Antibiotic Allergy Toolkit.mp4

Day 1 An Antibiotic Allergy Toolkit.pdf

Day 1 Antimicrobial Stewardship.mp4

Day 1 Antimicrobial Stewardship.pdf

Day 1 Clostridioides difficile Infection, Including Recurrent and Refractory Disease and Novel Approaches.mp4

Day 1 Clostridioides difficile Infection, Including Recurrent and Refractory Disease and Novel Approaches.pdf

Day 1 Infection Control 101 for the ID Clinician.mp4

Day 1 Infection Control 101 for the ID Clinician.pdf

Day 1 Introduction and Road Map Infectious Diseases of Adults.mp4

Day 1 Introduction and Road Map Infectious Diseases of Adults.pdf

Day 1 Live Q & A 1.mp4

Day 1 Live Q & A 2.mp4

Day 1 Live Q & A 3.mp4

Day 1 Live Q & A 4.mp4

Day 1 Panel Workshop #1 Resistant Gram-Positive Infections.pdf

Day 1 Panel Workshop #2 Resistant Gram-Negative Infections.pdf

Day 1 Plenary Highly Pathogenic Avian Influenza Uyeki Plenary will not be recorded (please read).pdf

Day 1 Principles of Antimicrobial Therapy.mp4

Day 1 Principles of Antimicrobial Therapy.pdf

Day 1 Skin and Soft Tissue Infections.mp4

Day 1 Skin and Soft Tissue Infections.pdf

Day 1 Update on Antifungal Diagnostics and Therapy.mp4

Day 1 Update on Antifungal Diagnostics and Therapy.pdf

Day 2 Bone and Joint Infections A Conceptual Framework.mp4

Day 2 Bone and Joint Infections A Conceptual Framework.pdf

Day 2 Encephalitis and Meningitis The Newest Guidelines and Best.mp4

Day 2 Encephalitis and Meningitis The Newest Guidelines and Best.pdf

Day 2 Keynote Lecture-Protecting Public Health with Vaccines Understanding Our Past, Protecting Our Future.pdf

Day 2 Live Q & A 1.mp4

Day 2 Live Q & A 2.mp4

Day 2 Live Q & A 3.mp4

Day 2 New and Emerging Viruses.mp4

Day 2 New and Emerging Viruses.pdf

Day 2 Panel Workshop #3 Native Bone Infections.mp4

Day 2 Panel Workshop #3 Native Bone Infections.pdf

Day 2 Panel Workshop #4 Orthopedic Device Infections Prosthetic Joint Infections.mp4

Day 2 Panel Workshop #4 Orthopedic Device Infections Prosthetic Joint Infections.pdf

Day 2 Staphylococcus aureus D‚j… Vu All Over Again.mp4

Day 2 Staphylococcus aureus D‚j… Vu All Over Again.pdf

Day 2 State-of-the-Art Diagnosis and Management of Sexually Transmitted Infections.pdf

Day 2 Tick Talk Lyme Disease, Ehrlichia, Anaplasma, Babesia, Rickettsia, and Other Tick-Borne Infections.pdf

Day 3 Advances in Viral Hepatitis HBV and HCV.mp4

Day 3 Advances in Viral Hepatitis HBV and HCV.pdf

Day 3 Critical Care ID.mp4

Day 3 Critical Care ID.pdf

Day 3 Endocarditis and Cardiac Device Infections.mp4

Day 3 Endocarditis and Cardiac Device Infections.pdf

Day 3 Live Q & A 1.mp4

Day 3 Live Q & A 2.mp4

Day 3 Live Q & A 3.mp4

Day 3 Live Q & A 4.mp4

Day 3 Panel Workshop #5 Multidisciplinary Management of Intraabdominal Infections (Including New Guidelines).mp4

Day 3 Panel Workshop #5 Multidisciplinary Management of Intraabdominal Infections (Including New Guidelines).pdf

Day 3 Panel Workshop #6 Challenges in Native Valve Endocarditis (Including in Persons with Substance Use Disorder).mp4

Day 3 Panel Workshop #6 Challenges in Native Valve Endocarditis (Including in Persons with Substance Use Disorder).pdf

Day 3 Panel Workshop #7 Multidisciplinary Management of Prosthetic Valve Endocarditis (Including in Persons with Substance Use Disorder).mp4

Day 3 Panel Workshop #7 Multidisciplinary Management of Prosthetic Valve Endocarditis (Including in Persons with Substance Use Disorder).pdf

Day 3 Panel Workshop #8 Multidisciplinary Management of Complex Urinary Tract Infections.mp4

Day 3 Panel Workshop #8 Multidisciplinary Management of Complex Urinary Tract Infections.pdf

Day 3 The Syndemic of SUD and Infection Updated Approaches for 2025.mp4

Day 3 The Syndemic of SUD and Infection Updated Approaches for 2025.pdf

Day 4 Flummoxing Cases in Fungal Infections.mp4

Day 4 Flummoxing Cases in Fungal Infections.pdf

Day 4 Infections in Hematologic Malignancies and Stem Cell Transplantation.mp4

Day 4 Infections in Hematologic Malignancies and Stem Cell Transplantation.pdf

Day 4 Infections Related to Solid Organ Transplant and Non-Oncologic Immunomodulatory Therapy.pdf

Day 4 Live Q & A 1.mp4

Day 4 Live Q & A 2.mp4

Day 4 Live Q & A 3.mp4

Day 4 Navigating New Vaccines Updates and Recommendations.mp4

Day 4 Navigating New Vaccines Updates and Recommendations.pdf

Day 4 Pre- and Post-Exposure Prophylaxis for HIV and STIs.pdf

Day 4 Understanding and Addressing the Continuing Challenges in HIVAssociated Opportunistic Infections.mp4

Day 4 Understanding and Addressing the Continuing Challenges in HIVAssociated Opportunistic Infections.pdf

Day 4 What’s New in the Care of People with HIV in 2025.mp4

Day 4 What’s New in the Care of People with HIV in 2025.pdf

Day 5 Bronchiectasis, Pneumonia, and NTM Infections Anatomic and Clinical Approaches.mp4

Day 5 Bronchiectasis, Pneumonia, and NTM Infections Anatomic and Clinical Approaches.pdf

Day 5 Cases in Global Infectious Diseases.mp4

Day 5 Cases in Global Infectious Diseases.pdf

Day 5 Eye and ENT Infections What You Need to Know in 2025.mp4

Day 5 Eye and ENT Infections What You Need to Know in 2025.pdf

Day 5 Full Live.mp4

Day 5 Kim – Viral Hepatitis.pdf

Day 5 Live New England Journal of Medicine Clinicopathologic Conference (CPC) NEJM CPC Embargo (please read).pdf

Day 5 Live New England Journal of Medicine Clinicopathologic Conference (CPC) NEJM CPC Presentation of Case – audience only.pdf

Day 5 Panel Workshop #10 Management of Complex Nontuberculous Mycobacterial (NTM) Infection Extrapulmonary.mp4

Day 5 Panel Workshop #10 Management of Complex Nontuberculous Mycobacterial (NTM) Infection Extrapulmonary.pdf

Day 5 Panel Workshop #9 Management of Complex Nontuberculous Mycobacterial (NTM) Infection Pulmonary.mp4

Day 5 Panel Workshop #9 Management of Complex Nontuberculous Mycobacterial (NTM) Infection Pulmonary.pdf

Day 5 The Latest on Major Respiratory Viral Infections.mp4

Day 5 The Latest on Major Respiratory Viral Infections.pdf

Day 5 Tuberculosis Update.mp4

Day 5 Tuberculosis Update.pdf

Harvard CME _ Infectious Diseases in Adults.pdf

NEJM CPC Embargo Notice.pdf